Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

NCT06025045 is registered in ClinicalTrials.gov with Jing Li as lead sponsor.

NCT NCT06025045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
Lead sponsor
Jing Li
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
August 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer stage iii, ovarian cancer stage iv